Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
Yannick Kaiser(Amsterdam University Medical Centers), Marc R. Dweck(British Heart Foundation), Marwa Daghem(University of Edinburgh), Pim van der Harst(Netherlands Heart Institute), Kang H. Zheng(Twitter (United States)), Michelle C. Williams(British Heart Foundation), Nick S. Nurmohamed(Amsterdam Neuroscience), Damini Dey(Cedars-Sinai Medical Center), Mhairi Doris(MACOM (United States)), Jacek Kwieciński(MACOM (United States)), Alastair J. Moss(MACOM (United States)), Mohammed N. Meah(University of Edinburgh), David E. Newby(British Heart Foundation), Jeffrey Kroon(University of Amsterdam), Philip D Adamson(MACOM (United States)), Erik S.G. Stroes(Amsterdam UMC Location University of Amsterdam), Evangelos Tzolos(Cedars-Sinai Medical Center)
Cited by 190
Related Papers
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
|European Heart Journal|2015|1.4k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease
|Circulation Research|2017|1.2k